Literature DB >> 3277454

Decision analysis and polio immunization policy.

A R Hinman1, J P Koplan, W A Orenstein, E W Brink.   

Abstract

Dr. Salk's comments on our paper fall into four major categories: our use of the techniques of decision analysis, the assumptions we used, the fact that we did not include individual and social values in the model, and the way in which vaccine policies are developed in the United States. We believe that the methods were used correctly, that the assumptions we used are defensible, and that our conclusions were both appropriate and appropriately worded. We explicitly did not include individual and social values since we were addressing the scientific and epidemiologic issues rather than ethical and moral issues. Vaccine policy development in the United States is carried out in public forums with opportunity for presentation of all sides of an issue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3277454      PMCID: PMC1349181          DOI: 10.2105/ajph.78.3.301

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  7 in total

1.  Poliomyelitis vaccination. Evaluation and direction in continuing application.

Authors:  A B Sabin
Journal:  Am J Clin Pathol       Date:  1978-07       Impact factor: 2.493

2.  The swine-influenza decision.

Authors:  S C Schoenbaum; B J McNeil; J Kavet
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

3.  Choice of preventive treatment for isoniazid-resistant tuberculous infection. Use of decision analysis and the Delphi technique.

Authors:  J P Koplan; L S Farer
Journal:  JAMA       Date:  1980-12-19       Impact factor: 56.272

4.  Public health policy toward atypical measles syndrome in the United States.

Authors:  A R Hinman; J P Koplan
Journal:  Med Decis Making       Date:  1982       Impact factor: 2.583

5.  Polio immunization policy in the United States: a new challenge for a new generation.

Authors:  D Salk
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

6.  Live or inactivated poliomyelitis vaccine: an analysis of benefits and risks.

Authors:  A R Hinman; J P Koplan; W A Orenstein; E W Brink; B M Nkowane
Journal:  Am J Public Health       Date:  1988-03       Impact factor: 9.308

Review 7.  Paralytic poliomyelitis: Old dogmas and new perspectives.

Authors:  A B Sabin
Journal:  Rev Infect Dis       Date:  1981 May-Jun
  7 in total
  3 in total

1.  A ten-year experience in control of poliomyelitis through a combination of live and killed vaccines in two developing areas.

Authors:  T Tulchinsky; Y Abed; S Shaheen; N Toubassi; Y Sever; M Schoenbaum; R Handsher
Journal:  Am J Public Health       Date:  1989-12       Impact factor: 9.308

2.  Social, economic and psychological impacts of childhood diseases subject to immunization.

Authors:  B Velimirovic
Journal:  Infection       Date:  1991 Jul-Aug       Impact factor: 3.553

Review 3.  Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication.

Authors:  Kimberly M Thompson; Dominika A Kalkowska
Journal:  Expert Rev Vaccines       Date:  2020-08-01       Impact factor: 5.217

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.